BRIEFING · THE CARE MAP
The website is not the whole care team
MYTH.One polished website tells you all you need to know.
FACT.As of September 2026, legitimate virtual care still depends on a real clinician, a real prescription and a pharmacy operating under the rules that apply to it.
Keep the chain in view. Check each link on its own.
Part one: the clinician
A doctor treating you over a screen must be as careful as one treating you in the same room.
The clinician is the person who decides on the prescription: a doctor, or sometimes a nurse practitioner or physician assistant. They need time to ask more questions, learn your health history and decide whether an online visit is enough to answer your medical question.
Part two: the product
As of September 2026, Ozempic, Rybelsus and Wegovy are FDA-approved products containing semaglutide; a pharmacy-made version is a different category.
Ask for the full product name. “Semaglutide” alone does not reveal whether the offer is an approved product, a compounded preparation or an unapproved item.
Part three: the pharmacy
As of September 2026, your state’s board of pharmacy was the main watchdog over an ordinary pharmacy that mixes medicines to order. The FDA was the main watchdog over outsourcing facilities, the larger plants that mix such medicines in batches for clinics and hospitals.
The pharmacy can be checked separately from the website arranging the visit. Get its name before money changes hands.
ANNOTATED READING LIST
Evidence, with a note on why it belongs
- Model rules for online care, from the state medical boards.The Federation of State Medical Boards, the national group of the boards that license doctors, wrote these rules as a pattern for states to follow. They are not law by themselves, but they say online care must be as careful as care in person.
- Compounding and the FDA: Questions and Answers.The FDA explains the two kinds of places that mix medicines to order, and who keeps watch over each.